News Related to Dual Checkpoint Blockade

Related coverage linked through entity extraction aliases.

Three New Glioblastoma Research Advances Target Diagnostics and Immunotherapy

Mar 10, 2026

Recent publications and collaborations advance glioblastoma research through blood-based microRNA diagnostics, combination immunotherapy trials, and identification of MOV10 as a prognostic biomarker and therapeutic target.

Gut Microbiome Diversity Predicts Response to Dual Immunotherapy in Advanced Lung Cancer

Feb 28, 2026

A prospective multicenter study found that baseline gut microbiome diversity selectively stratifies benefit from dual checkpoint blockade in advanced NSCLC, with high diversity associated with prolonged survival on immunotherapy alone while low diversity patients benefit from added chemotherapy.